PCOS

AhrensK,MumfordSL,SchliepKP,etal.Serumleptinlevelsandreproductivefunctionduringthemenstrual cycle.Am J Obstet Gynecol.2014;210(3):248. e1-9.

Arentz,Susan,etal.“CombinedLifestyleandHerbalMedicineinOverweightWomenwithPolycysticOvary Syndrome (PCOS): A Randomized Controlled Trial.” Phytotherapy Research, vol. 31, no. 9, July 2017, pp. 1330– 1340., doi:10.1002/ptr.5858.

BorissovaA,TankovaT,KirilovG,etal.TheeffectofvitaminD3oninsulinsecretionandperipheralinsulin sensitivity in type 2 diabetic patients,Int J Clin Pract2003;57:258-261.

Campbell,MD,andMJDimino.“TheFunctionandDifferentiationofOvarianMitochondria.”Biologyofthe Ovary. Developments in Obstetrics and Gynecology, vol. 2, Springer, 1980.

Cree-Green, Melanie, et al. “Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome.” Journal of the Endocrine Society, vol. 1, no. 7, Jan. 2017, pp. 931– 944., doi:10.1210/js.2017-00192.

Collman,G.TheExposome:RevealingtheEnvironment’sRoleinHealth.LifetimeExposuresandHuman Health: The Exposome Symposium, April 19, 2017https://publichealth.yale.edu/ehs/exposome/

GallettaM,GrassoS,VaiarelliA,RoseffSJ.Bye-byechiro-inositol–myo-inositol:trueprogressinthe treatment of polycystic ovary syndrome and ovulation induction.Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1212-4.

HelixMagazine.helix.northwestern.edu/article/thalidomide-tragedy-lessons-drug-safety-and-regulation.

Lindheim,Lisa,etal.“AlterationsinGutMicrobiomeCompositionandBarrierFunctionAreAssociatedwith Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.” Plos One, vol. 12, no. 1, Mar. 2017,

MavropoulosJC,YancyWS,HepburnJ,WestmanEC.Theeffectsofalow-carbohydrate,ketogenicdietonthe polycystic ovary syndrome: A pilot study.Nutr Metab(Lond). 2005;2:35.

May-Panloup,Pascale,etal.“OvarianAgeing:theRoleofMitochondriainOocytesandFollicles.”Human Reproduction Update, vol. 22, no. 6, 2016, pp. 725–743.,

Mohammadi,Shimaetal.“TheEffectofCurcuminonTNF-Α,IL-6andCRPExpressioninaModelofPolycystic Ovary Syndrome as an Inflammation State.” Journal of Reproduction & Infertility 18.4 (2017): 352–360. Print.

NestlerJ,JakubowiczD,ReamerP,GunnR,AllanG.Ovulatoryandmetaboliceffectsofd-chiro-inositolintheNordioM,ProiettiE.Thecombinedtherapywithmyo-inositolandD-chiro-inositolreducestheriskof

metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.Eur RevOnerG,MuderrisI.Clinical,endocrineandmetaboliceffectsofmetforminvsN-acteyl-cytseineinwomenwith

Pizzo,Alfonsa,etal.“ComparisonbetweenEffectsofMyo-InositolAndd-Chiro-InositolonOvarianFunctionand Metabolic Factors in Women with PCOS.” Gynecological Endocrinology, vol. 30, no. 3, 2013, pp. 205–208.,

Qin,JZetal.Obstetriccomplicationsinwomenwithpolycysticovarysyndrome:asystematicreviewandmeta-analysis Reproductive Biology and Endocrinology201311:56

RaghuramuluN,RaghunathM,ChandraS,etal.VitaminDimprovesoralglucosetoleranceandinsulinsecretion in human diabetes.J Clin Biochem Butr1992;13:45-51.

Refaeey,AbdelazizEl,etal.“CombinedCoenzymeQ10andClomipheneCitrateforOvulationInductionin

Clomiphene-Citrate-Resistant Polycystic Ovary Syndrome.” Reproductive BioMedicine Online, vol. 29, no. 1,2014, pp. 119–124.

Reddy,P.Sushma,etal.“BeneficialEffectofCurcumininLetrozoleInducedPolycysticOvarySyndrome.”Asian

Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. Journal of AffectiveDisorders,74(3), 299-304. doi:10.1016/s0165-0327(02)00117-9

RommA.BotanicalMedicineforWomen’sHealth.St.Louis,MO:ChurchillLivingstone;2010.

SjaardaLA,MumfordSL,KissellK,etalIncreasedandrogen,anti-Müllerianhormone,andsporadicanovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?J Clin Endocrinol Metab.2014;99(6):2208- 2216.

Saleem,Shemaila,etal.“PolycysticOvarianSyndrome;AssociationOfBodyMassIndexWithVitaminDLevels In Women.” The Professional Medical Journal, vol. 24, no. 06, Jan. 2017, pp. 834–838., Selimoglu, H., et al. “The Effect of Vitamin D Replacement Therapy on Insulin Resistance and Androgen Levels in Women with Polycystic Ovary Syndrome.” Journal of Endocrinological Investigation, vol. 33, no. 4, Sept. 2009, pp. 234–238.,

ThapliyalR,DeshpandeSS,MaruGB.Mechanism(s)ofturmeric-mediatedprotectiveeffectsagainst benzo(a)pyrene-derived DNA adducts.Cancer Lett2002;175:79-88.

ThysJacobsS,DonovanD,PapadopoulosA,etal.VitaminDandcalciumdysregulationinthepolycystic ovarian syndrome.Steroids1999;64:430-435

Wang,JeffG.,etal.“TheEffectofCinnamonExtractonInsulinResistanceParametersinPolycysticOvary Syndrome: a Pilot Study.” Fertility and Sterility, vol. 88, no. 1, 2007, pp. 240–243.